Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 14, 2023

BUY
$96.34 - $112.38 $2.08 Million - $2.43 Million
21,600 New
21,600 $2.22 Million
Q4 2020

Feb 16, 2021

SELL
$67.0 - $84.39 $1.23 Million - $1.55 Million
-18,400 Closed
0 $0
Q3 2020

Nov 16, 2020

BUY
$55.23 - $79.93 $1.02 Million - $1.47 Million
18,400 New
18,400 $1.43 Million

Others Institutions Holding HZNP

About Horizon Therapeutics Public Ltd Co


  • Ticker HZNP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 230,384,000
  • Description
  • Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...
More about HZNP
Track This Portfolio

Track Western Standard LLC Portfolio

Follow Western Standard LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Western Standard LLC, based on Form 13F filings with the SEC.

News

Stay updated on Western Standard LLC with notifications on news.